Skip to main content

Table 1 Clinical Characteristics of Patient Population (n = 10)

From: Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy

Case No.

Age

CV risk

Radiotherapy

Baseline LVEF (%)

Post Chemothx LVEF (%)

Trastuzumab Duration

1

33

None

Yes

55

52

4 months

2

41

HTN

Yes

60

58

5 months

3

27

None

Yes

54

56

4 months

4

39

None

Yes

65

62

3 months

5

44

Lipids

Yes

58

55

4 months

6

38

None

Yes

56

52

5 months

7

56

HTN

Yes

60

62

3 months

8

45

HTN

Yes

54

55

4 months

9

32

None

Yes

55

52

5 months

10

40

HTN

Yes

60

58

4 months

  1. CV, cardiovascular; LVEF, left ventricular ejection fraction; chemothx, chemotherapy; HTN, hypertension.